Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice.
van der Schoot LS, Janssen JJ, Bastiaens MT, de Boer-Brand A, Christiaansen-Smit C, Enomoto DNH, Hovingh R, Tupker RA, Seyger MMB, Verhoef LM, van den Reek JMPA, de Jong EMGJ. van der Schoot LS, et al. Among authors: verhoef lm. J Dermatolog Treat. 2023 Dec;34(1):2186728. doi: 10.1080/09546634.2023.2186728. J Dermatolog Treat. 2023. PMID: 36867069 Free PMC article.
Patients' perspectives towards biologic dose reduction in psoriasis: a qualitative study.
van der Schoot LS, Verhoef LM, van Ee I, van Oort FPAH, Pieterse AH, Seyger MMB, de Jong EMGJ, van den Reek JMPA. van der Schoot LS, et al. Among authors: verhoef lm. Arch Dermatol Res. 2023 Aug;315(6):1735-1745. doi: 10.1007/s00403-023-02566-w. Epub 2023 Feb 23. Arch Dermatol Res. 2023. PMID: 36813868 Free PMC article.
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Verhoef LM, van den Bemt BJ, van der Maas A, Vriezekolk JE, Hulscher ME, van den Hoogen FH, Jacobs WC, van Herwaarden N, den Broeder AA. Verhoef LM, et al. Cochrane Database Syst Rev. 2019 May 24;5(5):CD010455. doi: 10.1002/14651858.CD010455.pub3. Cochrane Database Syst Rev. 2019. PMID: 31125448 Free PMC article.
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial.
Michielsens CA, den Broeder N, van den Hoogen FH, Mahler EA, Teerenstra S, van der Heijde D, Verhoef LM, den Broeder AA. Michielsens CA, et al. Among authors: verhoef lm. Ann Rheum Dis. 2022 Oct;81(10):1392-1399. doi: 10.1136/annrheumdis-2022-222260. Epub 2022 Jun 14. Ann Rheum Dis. 2022. PMID: 35701155 Clinical Trial.
Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study).
van der Togt CJT, Verhoef LM, van den Bemt BJF, den Broeder N, Ter Heine R, den Broeder AA. van der Togt CJT, et al. Among authors: verhoef lm. Ther Adv Musculoskelet Dis. 2022 Dec 12;14:1759720X221142277. doi: 10.1177/1759720X221142277. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 36533097 Free PMC article.
39 results